Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
biopharma-reporter
17h
Atalanta Therapeutics raises $97 million to advance RNAi therapies for CNS disorders
The oversubscribed Series B will boost the clinical development of two RNAi therapies for epilepsy and Huntington’s disease ...
biopharma-reporter
12h
Setback for Inhibikase Parkinson’s therapy
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
All aboard feared dead
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Michigan priest loses license
Agency halts events
Signs education orders
Ex-worker admits to theft
Victims of DC plane crash
'As Tears Go By' singer dies
Blames DEI for crash
Shiffrin finishes 10th
Searching for joyriders
DOJ weighs dropping case?
Senate confirmation hearing
Syria’s transitional pres
Gun trafficking indictments
Day 2 of Senate hearing
First spacewalk together
Zeldin confirmed by Senate
Plans job, output cuts in US
In talks to invest in OpenAI
US economy grew 2.3%
Ebola outbreak in Uganda
S3 release date revealed
Wildfire erupts in NC
Deputy shooting sentence
Jury weighs charges
Presidential historian dies
Hamas frees more hostages
DOJ sues to block deal
Hamas confirms death
Weekly jobless claims fall
Feedback